The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | 1,017 | 2,036 | 2,259 | 2,332 |
| Provision for doubtful accounts | 69 | 98 | 63 | 39 |
| Depreciation | 3,044 | 3,138 | 3,070 | 6,166 |
| Loss on disposal of and reserve adjustments for medical equipment | 202 | 182 | -43 | 380 |
| Gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property | -123 | 1,026 | 559 | 1,723 |
| Amortization of intangible assets | 209 | 211 | 214 | 495 |
| Amortization of deferred debt issuance costs | 21 | 20 | 22 | 39 |
| Stock-based compensation | 1,233 | 1,272 | 1,322 | 1,769 |
| Deferred income taxes | 400 | 196 | 1,167 | 1,363 |
| Accounts receivable | 2,250 | -2,430 | 78 | 2,089 |
| Inventories | 203 | -199 | -78 | -863 |
| Other current assets | 130 | 141 | 786 | -24 |
| Other assets | -563 | 914 | 78 | -1,106 |
| Accounts payable and other liabilities | -3,328 | -575 | 1,842 | -1,975 |
| Net cash provided by operating activities | 970 | 7,126 | 8,493 | 8,789 |
| Acquisition of business | - | 0 | 0 | 1,412 |
| Purchase of medical equipment | 1,680 | 2,785 | 1,027 | 4,314 |
| Purchase of property and equipment | 157 | 133 | 79 | 348 |
| Proceeds from sale of medical equipment, property and equipment | 577 | 726 | 854 | 1,728 |
| Net cash used in investing activities | -1,260 | -2,192 | -252 | -4,346 |
| Principal payments on long-term debt | 6,145 | 8,084 | 14,004 | 30,261 |
| Cash proceeds from long-term debt | 6,145 | 6,724 | 8,785 | 32,717 |
| Debt issuance costs | - | -33 | 218 | 12 |
| Common stock repurchased as part of share repurchase program | 809 | 1,306 | 2,168 | 6,395 |
| Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans | 165 | 69 | 578 | 458 |
| Cash proceeds from exercise of options and espp | 184 | -1 | 177 | 159 |
| Net cash (used in) provided by financing activities | -790 | -2,703 | -8,006 | -4,250 |
| Net change in cash and cash equivalents | -1,080 | 2,231 | 235 | 193 |
| Cash and cash equivalents, beginning of period | 3,186 | 955 | 527 | - |
| Cash and cash equivalents, end of period | 2,106 | 3,186 | 955 | - |
InfuSystem Holdings, Inc (INFU)
InfuSystem Holdings, Inc (INFU)